BMY on XNYS, Health Care, Bristol-Myers Squibb Co., job postings
Measures activity, not value. Not investment advice.
Layoff notice covers 265 workers while 12-month profit rose 53% and the stock gained 28% in a year.
GoodLatest quarter revenue up 6.9% to $13.1B
WatchPast layoff-notice filers beat sector by median 11.0 points in 12 months
Written by AI from the data on this page, 21 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
expected around 4 Feb 2027 (an estimate: a year ago it reported on 5 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $13.1B, net income $2.2B.
31 Dec 2021RevenueNet incomeNet losstallest bar $13.1B30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$13.1B
$2.2B
30 Jun 2026
$13.0B
$3.3B
31 Mar 2026
$11.5B
$2.7B
31 Dec 2025
$12.5B
$1.1B
30 Sep 2025
$12.2B
$2.2B
30 Jun 2025
$12.3B
$1.3B
31 Mar 2025
$11.2B
$2.5B
31 Dec 2024
$12.3B
$72.0M
30 Sep 2024
$11.9B
$1.2B
30 Jun 2024
$12.2B
$1.7B
31 Mar 2024
$11.9B
-$11.9B
31 Dec 2023
$11.5B
$1.8B
30 Sep 2023
$11.0B
$1.9B
30 Jun 2023
$11.2B
$2.1B
31 Mar 2023
$11.3B
$2.3B
31 Dec 2022
$11.4B
$2.0B
30 Sep 2022
$11.2B
$1.6B
30 Jun 2022
$11.9B
$1.4B
31 Mar 2022
$11.6B
$1.3B
31 Dec 2021
$12.0B
$2.4B
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$50.0B
$48.0B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+4.2%
+11%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$9.2B
$6.0B
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$4.51
$2.96
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
69.2%
69.5%
73.2%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
–
–
-25.0%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
18.5%
12.6%
-18.2%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
44.1%
-58.8%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$9.3B
$15.3B
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$12.6B
$16.5B
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$42.9B
$49.0B
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$30.3B
$32.5B
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
1.8
0.0
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$11.45
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
13.0
19.3
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
2.4
5.0
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
3.0
5.0
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
5.1
2.0
Dividend yieldiDividends per share declared in the latest fiscal year divided by the share price.
4.2%
2.5%
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$678K
bought $0, sold $678K
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+2.9%
2,535 13F filers vs 2,464
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
80%
1.6B shares held by 13F filers (30 Sep 2026) of 2.0B outstanding (21 Oct 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
2.3%
46.8M shares sold short (30 Oct 2026) of 2.0B outstanding (21 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
4.2
46.8M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-6.2%
49.9M shares sold short in the report before, 46.8M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
40%
40% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 48%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
659
Tracked since 20 Nov 2026
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
Tracking started 20 Nov 2026; the change shows after 30 days.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
+20%
298 vs 248 applications
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+6.9%
$13.1B vs $12.2B (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+7.5%
$344.0M vs $320.0M (quarter ended 30 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$8.8M
4 quarters, $
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
718
the 12 months before: 1,399
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
88
88 articles in the last 7 days; its usual week has 8.5 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
10×
88 articles in the last 7 days; its usual week has 8.5.
Unusual now sharp changes in the last 90 days, compared with its own past
Visa applications 41, 4.6× a year earlier
Layoff notice 265 workers
Short interest 45.9M, 1.5× a year earlier
New lobbying issue
Price $58.80 on 20 Nov 2026, +28% over 12 months (12-month range $45.94 to $68.09)
Sharp change
8-K and other filings
WARN layoff notice
Lobbying filing
Insider net buying (open market). Insiders sold a net $2.5M in the last 12 months (the 12 months before: -$2.3M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 298 published in the last 12 months, +21% on the 12 months before.Revenue per quarter. Revenue $13.1B in the latest quarter, +6.9% on a year earlier.Capital spending per quarter. Capital spending $344.0M in the latest quarter, +7.5% on a year earlier.Institutional holders (13F filers). 2,535 13F filers reported holding it in the latest 13F quarter, +18% on a year earlier.Lobbying spend. Lobbying spend: $8.8M published in the last 12 months, -8.9% on the 12 months before.Workers in WARN layoff notices. Workers in WARN layoff notices: 828 published in the last 12 months, -36% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations.
Quarter ended 31 Dec 2021: $12.0B, +8.3% on a year earlier; public on 10 Feb 2022
Quarter ended 31 Mar 2022: $11.6B, +5.2% on a year earlier; public on 30 Apr 2022
Quarter ended 30 Jun 2022: $11.9B, +1.6% on a year earlier; public on 28 Jul 2022
Quarter ended 30 Sep 2022: $11.2B, -3.5% on a year earlier; public on 27 Oct 2022
Quarter ended 31 Dec 2022: $11.4B, -4.8% on a year earlier; public on 15 Feb 2023
Quarter ended 31 Mar 2023: $11.3B, -2.7% on a year earlier; public on 28 Apr 2023
Quarter ended 30 Jun 2023: $11.2B, -5.6% on a year earlier; public on 28 Jul 2023
Quarter ended 30 Sep 2023: $11.0B, -2.2% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $11.5B, +0.6% on a year earlier; public on 14 Feb 2024
Quarter ended 31 Mar 2024: $11.9B, +4.7% on a year earlier; public on 26 Apr 2024
Quarter ended 30 Jun 2024: $12.2B, +8.7% on a year earlier; public on 27 Jul 2024
Quarter ended 30 Sep 2024: $11.9B, +8.4% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $12.3B, +7.5% on a year earlier; public on 13 Feb 2025
Quarter ended 31 Mar 2025: $11.2B, -5.6% on a year earlier; public on 25 Apr 2025
Quarter ended 30 Jun 2025: $12.3B, +0.6% on a year earlier; public on 1 Aug 2025
Quarter ended 30 Sep 2025: $12.2B, +2.8% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $12.5B, +1.3% on a year earlier; public on 12 Feb 2026
Quarter ended 31 Mar 2026: $11.5B, +2.6% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $13.0B, +5.7% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $13.1B, +6.9% on a year earlier; public on 30 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $320.0M, +13% on a year earlier; public on 10 Feb 2022
Quarter ended 31 Mar 2022: $253.0M, +46% on a year earlier; public on 30 Apr 2022
Quarter ended 30 Jun 2022: $272.0M, +30% on a year earlier; public on 28 Jul 2022
Quarter ended 30 Sep 2022: $247.0M, -8.5% on a year earlier; public on 27 Oct 2022
Quarter ended 31 Dec 2022: $346.0M, +8.1% on a year earlier; public on 15 Feb 2023
Quarter ended 31 Mar 2023: $278.0M, +9.9% on a year earlier; public on 28 Apr 2023
Quarter ended 30 Jun 2023: $259.0M, -4.8% on a year earlier; public on 28 Jul 2023
Quarter ended 30 Sep 2023: $342.0M, +38% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $330.0M, -4.6% on a year earlier; public on 14 Feb 2024
Quarter ended 31 Mar 2024: $284.0M, +2.2% on a year earlier; public on 26 Apr 2024
Quarter ended 30 Jun 2024: $262.0M, +1.2% on a year earlier; public on 27 Jul 2024
Quarter ended 30 Sep 2024: $324.0M, -5.3% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $378.0M, +15% on a year earlier; public on 13 Feb 2025
Quarter ended 31 Mar 2025: $260.0M, -8.5% on a year earlier; public on 25 Apr 2025
Quarter ended 30 Jun 2025: $361.0M, +38% on a year earlier; public on 1 Aug 2025
Quarter ended 30 Sep 2025: $320.0M, -1.2% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $370.0M, -2.1% on a year earlier; public on 12 Feb 2026
Quarter ended 31 Mar 2026: $347.0M, +33% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $305.0M, -16% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $344.0M, +7.5% on a year earlier; public on 30 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 2,162; public on 14 Feb 2022
31 Mar 2022 report: 2,338; public on 16 May 2022
30 Jun 2022 report: 2,372; public on 15 Aug 2022
30 Sep 2022 report: 2,263; public on 14 Nov 2022
31 Dec 2022 report: 2,377; public on 14 Feb 2023
31 Mar 2023 report: 2,363; public on 15 May 2023
30 Jun 2023 report: 2,269; public on 14 Aug 2023
30 Sep 2023 report: 2,187; public on 14 Nov 2023
31 Dec 2023 report: 2,171; public on 14 Feb 2024
31 Mar 2024 report: 2,196; public on 15 May 2024
30 Jun 2024 report: 2,018; public on 14 Aug 2024
30 Sep 2024 report: 2,124; public on 14 Nov 2024
31 Dec 2024 report: 2,326; public on 14 Feb 2025
31 Mar 2025 report: 2,349; public on 15 May 2025
30 Jun 2025 report: 2,178; public on 14 Aug 2025
30 Sep 2025 report: 2,140; public on 14 Nov 2025
31 Dec 2025 report: 2,330; public on 17 Feb 2026
31 Mar 2026 report: 2,443; public on 15 May 2026
30 Jun 2026 report: 2,464; public on 14 Aug 2026
30 Sep 2026 report: 2,535; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $760K published
Quarter from 1 Apr 2022: $2.4M published
Quarter from 1 Jul 2022: $1.7M published
Quarter from 1 Oct 2022: $950K published
Quarter from 1 Jan 2023: $750K published
Quarter from 1 Apr 2023: $2.5M published
Quarter from 1 Jul 2023: $2.3M published
Quarter from 1 Oct 2023: $2.3M published
Quarter from 1 Jan 2024: $2.2M published
Quarter from 1 Apr 2024: $720K published
Quarter from 1 Jul 2024: $760K published
Quarter from 1 Oct 2024: $3.3M published
Quarter from 1 Jan 2025: $810K published
Quarter from 1 Apr 2025: $870K published
Quarter from 1 Jul 2025: $4.8M published
Quarter from 1 Oct 2025: $3.2M published
Quarter from 1 Jan 2026: $1.2M published
Quarter from 1 Jul 2026: $4.5M published
Quarter from 1 Oct 2026: $3.0M published
Workers in WARN layoff notices
Month from 1 May 2023: 48 published
Month from 1 Sep 2023: 108 published
Month from 1 Mar 2024: 290 published
Month from 1 Apr 2024: 75 published
Month from 1 Jun 2024: 863 published
Month from 1 Aug 2024: 117 published
Month from 1 Oct 2024: 79 published
Month from 1 Mar 2025: 290 published
Month from 1 May 2025: 649 published
Month from 1 Jul 2025: 68 published
Month from 1 Oct 2025: 282 published
Month from 1 Dec 2025: 110 published
Month from 1 Mar 2026: 247 published
Month from 1 May 2026: 206 published
Month from 1 Oct 2026: 265 published
What is unusual now
Made public in the last 90 days: it had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year; it also filed a WARN layoff notice covering 265 workers within 30 days (Princeton, NJ). 4 sharp changes in all. Two or more unrelated kinds of activity agreed on 18 Aug 2026.
Wikipedia attention spike: drew 6,796 Wikipedia page views in the week of 3 Aug 2026, 2.3× the same week last year Public on 11 Aug 2026.
H-1B/E-3 applications change: had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year Public on 12 Nov 2026.
Short interest spike: had 52.3M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year Public on 12 Aug 2026.
Latest records
The names and amounts behind the totals, newest first
659 open postings; careers site tracked since 20 Nov 2026. Most in Research & science 9%, Marketing & communications 4%, ML / AI 4%, Manufacturing & production 3%.
Reported lobbying spend: $3.0M in Q3 2026, $3.2M in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
1 Jul 2026
New
Advanced Policy Consulting, LLCfor Bristol-Myers Squibb Company
Education regarding the value of biopharmaceutical innovation and related issues.Health issues
Two or more unrelated kinds of records unusual within 30 days
18 Aug 2026confirmed
Confirmed across sources Attention and Hiring and Layoff notices and Lobbying and Short interest and volume
Bristol-Myers Squibb(BMY): drew 6,796 Wikipedia page views in the week of 3 Aug 2026, 2.3× the same week last year; it also had 52.3M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year; it also filed a WARN layoff notice covering 265 workers within 30 days (Princeton, NJ); it also lobbying on a new issue; and it had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year. Five unrelated kinds of activity within 93 days.
Attention: Wikipedia attention spike, became public on 11 Aug 2026
Short interest and volume: Short interest spike, became public on 12 Aug 2026
Short interest and volume: Short interest spike, became public on 26 Aug 2026
Layoff notices: WARN layoff notice, became public on 1 Oct 2026
Lobbying: Lobbying on a new issue, became public on 21 Oct 2026
Hiring: H-1B/E-3 applications change, became public on 12 Nov 2026
The week of 3 Aug 2026 against the 26 weeks before it.
this weekearliernormal: 2,177See the evidence (6 changes)
Attention: Wikipedia attention spike became public on 11 Aug 2026
Bristol-Myers Squibb drew 6,796 Wikipedia page views in the week of 3 Aug 2026, 2.3× the same week last year.
This period
6,796 (the week of 3 Aug 2026)
Normal week (median of 26 earlier)
2,177
Typical spread (median absolute deviation)
104
How far from its usual level
+21.2
Same week last year
2,895
History used
2,777 days
the week of 3 Aug 202626 earlier weeksnormal: 2,177
Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.
Short interest and volume: Short interest spike became public on 12 Aug 2026
Bristol-Myers Squibb had 52.3M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year.
This period
52.3M (the 31 Jul 2026 report)
Normal report (median of 24 earlier)
31.9M
Typical spread (median absolute deviation)
2.0M
How far from its usual level
+6.4
Same report last year
30.9M
History used
3,136 days
the 31 Jul 2026 report24 earlier reportsnormal: 31.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 26 Aug 2026
Bristol-Myers Squibb had 45.9M shares sold short in the 14 Aug 2026 report, 1.5× the same report last year.
This period
45.9M (the 14 Aug 2026 report)
Normal report (median of 24 earlier)
32.2M
Typical spread (median absolute deviation)
2.5M
How far from its usual level
+3.7
Same report last year
29.7M
History used
3,150 days
the 14 Aug 2026 report24 earlier reportsnormal: 32.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Fires on a WARN notice after 30 days without one; notices within 30 days are summed.
Lobbying: Lobbying on a new issue became public on 21 Oct 2026
Bristol-Myers Squibb lobbying on a new issue.
New
['DEF']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
4288795
Hiring: H-1B/E-3 applications change became public on 12 Nov 2026
Bristol-Myers Squibb had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year.
This period
41 (August 2026)
Normal month (median of 5 earlier)
12
Typical spread (median absolute deviation)
3
How far from its usual level
+6.5
Same month last year
9
History used
2,520 days
August 20265 earlier monthsnormal: 12
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
1 Oct 2025confirmed
Confirmed across sources Hiring and Layoff notices
Bristol-Myers Squibb(BMY): had 44 H-1B/E-3 visa applications certified in June 2025, 2.9× the same month last year, while it filed a WARN layoff notice covering 282 workers within 30 days (Lawrence Twp, NJ). Two unrelated kinds of activity within 28 days.
Hiring: H-1B/E-3 applications change, became public on 31 Aug 2025
Layoff notices: WARN layoff notice, became public on 1 Oct 2025
June 2025 against the 5 months before it.
this monthearliernormal: 15See the evidence (2 changes)
Hiring: H-1B/E-3 applications change became public on 31 Aug 2025
Bristol-Myers Squibb had 44 H-1B/E-3 visa applications certified in June 2025, 2.9× the same month last year.
This period
44 (June 2025)
Normal month (median of 5 earlier)
15
Typical spread (median absolute deviation)
3
How far from its usual level
+6.5
Same month last year
15
History used
2,093 days
June 20255 earlier monthsnormal: 15
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.
Fires on a WARN notice after 30 days without one; notices within 30 days are summed.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
20 Aug 2024confirmed
Confirmed across sources Hiring and Institutional holdings and Layoff notices
Bristol-Myers Squibb(BMY): saw 134 13F filers open a new position in the quarter ended 30 Jun 2024, 1.7× the same quarter last year; it also had 48 H-1B/E-3 visa applications certified in May 2024, 1.3× the same month last year; and it filed a WARN layoff notice covering 79 workers within 30 days (Lawrenceville, NJ). Three unrelated kinds of activity within 61 days.
Layoff notices: WARN layoff notice, became public on 1 Aug 2024
Institutional holdings: Many funds opening a new position, became public on 14 Aug 2024
Hiring: H-1B/E-3 applications change, became public on 13 Sep 2024
Layoff notices: WARN layoff notice, became public on 1 Oct 2024
The quarter ended 30 Jun 2024 against the 8 quarters before it.
this quarterearliernormal: 81.5See the evidence (4 changes)
Layoff notices: WARN layoff notice became public on 1 Aug 2024
Bristol-Myers Squibb filed a WARN layoff notice covering 117 workers within 30 days (Lawrenceville, NJ).
Fires on a WARN notice after 30 days without one; notices within 30 days are summed.
Institutional holdings: Many funds opening a new position became public on 14 Aug 2024
Bristol-Myers Squibb saw 134 13F filers open a new position in the quarter ended 30 Jun 2024, 1.7× the same quarter last year.
This period
134 (the quarter ended 30 Jun 2024)
Normal quarter (median of 8 earlier)
81.5
Typical spread (median absolute deviation)
8
How far from its usual level
+4.4
Same quarter last year
77
History used
3,926 days
the quarter ended 30 Jun 20248 earlier quartersnormal: 81.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Hiring: H-1B/E-3 applications change became public on 13 Sep 2024
Bristol-Myers Squibb had 48 H-1B/E-3 visa applications certified in May 2024, 1.3× the same month last year.
This period
48 (May 2024)
Normal month (median of 4 earlier)
21.5
Typical spread (median absolute deviation)
0.5
How far from its usual level
+8.8
Same month last year
36
History used
1,698 days
May 20244 earlier monthsnormal: 21.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.
Fires on a WARN notice after 30 days without one; notices within 30 days are summed.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
12 Nov 2026Hiring change
had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year.
Same month last year: 9; its normal month is 12.
See the evidence
This period
41 (August 2026)
Normal month (median of 5 earlier)
12
Typical spread (median absolute deviation)
3
How far from its usual level
+6.5
Same month last year
9
History used
2,520 days
August 20265 earlier monthsnormal: 12
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.
had 45.9M shares sold short in the 14 Aug 2026 report, 1.5× the same report last year.
Same report last year: 29.7M; its normal report is 32.2M.
See the evidence
This period
45.9M (the 14 Aug 2026 report)
Normal report (median of 24 earlier)
32.2M
Typical spread (median absolute deviation)
2.5M
How far from its usual level
+3.7
Same report last year
29.7M
History used
3,150 days
the 14 Aug 2026 report24 earlier reportsnormal: 32.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
drew 6,796 Wikipedia page views in the week of 3 Aug 2026, 2.3× the same week last year; it also had 52.3M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year; it also filed a WARN layoff notice covering 265 workers within 30 days (Princeton, NJ); it also lobbying on a new issue; and it had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year. Five unrelated kinds of activity within 93 days.
See the evidence (6 changes)
Attention: Wikipedia attention spike became public on 11 Aug 2026
Bristol-Myers Squibb drew 6,796 Wikipedia page views in the week of 3 Aug 2026, 2.3× the same week last year.
This period
6,796 (the week of 3 Aug 2026)
Normal week (median of 26 earlier)
2,177
Typical spread (median absolute deviation)
104
How far from its usual level
+21.2
Same week last year
2,895
History used
2,777 days
the week of 3 Aug 202626 earlier weeksnormal: 2,177
Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.
Short interest and volume: Short interest spike became public on 12 Aug 2026
Bristol-Myers Squibb had 52.3M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year.
This period
52.3M (the 31 Jul 2026 report)
Normal report (median of 24 earlier)
31.9M
Typical spread (median absolute deviation)
2.0M
How far from its usual level
+6.4
Same report last year
30.9M
History used
3,136 days
the 31 Jul 2026 report24 earlier reportsnormal: 31.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 26 Aug 2026
Bristol-Myers Squibb had 45.9M shares sold short in the 14 Aug 2026 report, 1.5× the same report last year.
This period
45.9M (the 14 Aug 2026 report)
Normal report (median of 24 earlier)
32.2M
Typical spread (median absolute deviation)
2.5M
How far from its usual level
+3.7
Same report last year
29.7M
History used
3,150 days
the 14 Aug 2026 report24 earlier reportsnormal: 32.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Fires on a WARN notice after 30 days without one; notices within 30 days are summed.
Lobbying: Lobbying on a new issue became public on 21 Oct 2026
Bristol-Myers Squibb lobbying on a new issue.
New
['DEF']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
4288795
Hiring: H-1B/E-3 applications change became public on 12 Nov 2026
Bristol-Myers Squibb had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year.
This period
41 (August 2026)
Normal month (median of 5 earlier)
12
Typical spread (median absolute deviation)
3
How far from its usual level
+6.5
Same month last year
9
History used
2,520 days
August 20265 earlier monthsnormal: 12
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
12 Aug 2026Short interest and volume change
had 52.3M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year.
Same report last year: 30.9M; its normal report is 31.9M.
See the evidence
This period
52.3M (the 31 Jul 2026 report)
Normal report (median of 24 earlier)
31.9M
Typical spread (median absolute deviation)
2.0M
How far from its usual level
+6.4
Same report last year
30.9M
History used
3,136 days
the 31 Jul 2026 report24 earlier reportsnormal: 31.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
drew 6,796 Wikipedia page views in the week of 3 Aug 2026, 2.3× the same week last year.
Same week last year: 2,895; its normal week is 2,177.
See the evidence
This period
6,796 (the week of 3 Aug 2026)
Normal week (median of 26 earlier)
2,177
Typical spread (median absolute deviation)
104
How far from its usual level
+21.2
Same week last year
2,895
History used
2,777 days
the week of 3 Aug 202626 earlier weeksnormal: 2,177
Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.
had 44 H-1B/E-3 visa applications certified in June 2025, 2.9× the same month last year, while it filed a WARN layoff notice covering 282 workers within 30 days (Lawrence Twp, NJ). Two unrelated kinds of activity within 28 days.
See the evidence (2 changes)
Hiring: H-1B/E-3 applications change became public on 31 Aug 2025
Bristol-Myers Squibb had 44 H-1B/E-3 visa applications certified in June 2025, 2.9× the same month last year.
This period
44 (June 2025)
Normal month (median of 5 earlier)
15
Typical spread (median absolute deviation)
3
How far from its usual level
+6.5
Same month last year
15
History used
2,093 days
June 20255 earlier monthsnormal: 15
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.
Fires on a WARN notice after 30 days without one; notices within 30 days are summed.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
1 Oct 2025Layoff notices change
filed a WARN layoff notice covering 282 workers within 30 days (Lawrence Twp, NJ).
had 44 H-1B/E-3 visa applications certified in June 2025, 2.9× the same month last year.
Same month last year: 15; its normal month is 15.
See the evidence
This period
44 (June 2025)
Normal month (median of 5 earlier)
15
Typical spread (median absolute deviation)
3
How far from its usual level
+6.5
Same month last year
15
History used
2,093 days
June 20255 earlier monthsnormal: 15
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.
Fires on a WARN notice after 30 days without one; notices within 30 days are summed.
Showing the newest 40 of 196 entries; narrow the window or the kind of data to see older ones.
Not listed: 250 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0000014272
Ticker
BMY
Domain
bms.com
Employer name
adnexus a bristol myers squibb rd, Bristol-Myers Squibb Company, E.R. Squibb & Sons LLC, turning point therapeutics (4 unverified)
Fein
13-6121983 (1 unverified)
Hq location
NJ|PRINCETON|08543 (1 unverified)
Lobbying client
bristol myers squibb, bristol myers squibb australia, juno therapeutics, karuna therapeutics and 1 more
Name
1096271 BC ULC, 2seventy bio, Inc, 2seventy bio Securities Corporation, 345 Park LLC and 213 more
Wikidata
Q266423
Wikipedia
Bristol Myers Squibb
DOL H-1B labor condition applications and PERM certifications1722 data points7 Oct 2019 to 28 Sep 2026
Federal lobbying disclosures (LDA)134 records, 279 data points30 Dec 1899 to 30 Sep 2026
SEC Form 13F institutional holdings9 records, 481 data points30 Jun 2013 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)205 records12 Jan 2016 to 29 Oct 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1256 data points31 Dec 2006 to 21 Oct 2026
SEC Form 4 insider transactions104 records, 336 data points6 Jan 2016 to 6 Nov 2026
FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
WARN layoff notices (state labor agencies)22 records, 60 data points1 Nov 2004 to 1 Sep 2026
Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026